WHO SMART Guidelines - HIV
0.4.3 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.4.3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Draft as of 2025-02-07 |
<Library xmlns="http://hl7.org/fhir">
<id value="HIVIND12Logic"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"/>
<profile
value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"/>
<profile
value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<div>
<table class="grid dict">
<tr>
<th scope="row"><b>Title: </b></th>
<td style="padding-left: 4px;">HIV.IND.12 Logic</td>
</tr>
<tr>
<th scope="row"><b>Id: </b></th>
<td style="padding-left: 4px;">HIVIND12Logic</td>
</tr>
<tr>
<th scope="row"><b>Version: </b></th>
<td style="padding-left: 4px;">0.4.3</td>
</tr>
<tr>
<th scope="row"><b>Url: </b></th>
<td style="padding-left: 4px;"><a href="Library-HIVIND12Logic.html">HIV.IND.12 Logic</a></td>
</tr>
<tr>
<th scope="row"><b>Status: </b></th>
<td style="padding-left: 4px;">draft</td>
</tr>
<tr>
<th scope="row"><b>Experimental: </b></th>
<td style="padding-left: 4px;">true</td>
</tr>
<tr>
<th scope="row"><b>Type: </b></th>
<td style="padding-left: 4px;">
<p style="margin-bottom: 5px;">
<b>system: </b> <span><a href="http://terminology.hl7.org/6.0.2/CodeSystem-library-type.html">http://terminology.hl7.org/CodeSystem/library-type</a></span>
</p>
<p style="margin-bottom: 5px;">
<b>code: </b> <span>logic-library</span>
</p>
</td>
</tr>
<tr>
<th scope="row"><b>Date: </b></th>
<td style="padding-left: 4px;">2025-02-07 14:15:45+0000</td>
</tr>
<tr>
<th scope="row"><b>Publisher: </b></th>
<td style="padding-left: 4px;">WHO</td>
</tr>
<tr>
<th scope="row"><b>Description: </b></th>
<td style="padding-left: 4px;"><div><p>% of person-years of follow-up (PYFU) on OAMT among opioid dependent people</p>
</div></td>
</tr>
<tr>
<td colspan="2">
<table>
<tr><th><a id="cql-content"><b>Content: </b></a> text/cql</th></tr>
<tr><td><pre><code class="language-cql">/**
* Library: HIV.IND.12 Logic
* Ref No: PRV.12
* Short Name: Total person-years on OAMT
*
* Definition: % of person-years of follow-up (PYFU) on OAMT among opioid dependent people
*
* Numerator: Total PYFU on OAMT during defined reporting period. | Calculated from the sum of the time on OAMT of each OAMT recipient during the reporting period.
* Numerator Calculation: SUM of [DIFFERENCE in MIN("Date OAMT initiated", "Reporting period start date") and MAX("Date of loss to follow-up or OAMT stopped", "Reporting period end date")] for all clients with "Medications prescribed" IN 'Methadone', 'Buprenorphine'
* Numerator Exclusions:
*
* Denominator: a) Programme/service provider level: estimated PYFU for all opioid dependent people accessing service during defined reporting period | b) Population level: estimated PYFU for total population of opioid dependent people in relevant geographic area during defined reporting period
* Denominator Calculation: Service level: Not calculated in DAK | | Population denominator: | *Estimated PYFU for all opioid-dependent people accessing service during defined reporting period | | Note: Can be reported only as numerator; by population or service level if these denominator estimates available.
* Denominator Exclusions:
*
* Disaggregations:
* • Gender (female, male, other*)
* • Age (15–19, 20–24, 25–49, 50+ years)
* • Provider type (key population-led or community-led organization, public sector provider, other entities such as private for-profit and not-for-profit organizations, including faith-based, international, nongovernmental)
* • Setting: facility-based service (including hospitals, health clinics, general practice offices, etc.) or community-based service (including drop-in centres, community service delivery points, mobile clinics or vans, outreach teams, community support groups, etc.)
* • Cities and other administrative regions of epidemiologic importance
*
* Disaggregation Elements: Gender | Age
*
* Numerator and Denominator Elements:
* Date OAMT initiated
* Date of loss to follow-up or OAMT stopped
* Medications prescribed
* Reporting period end date
* Reporting period start date
*
* Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
*
* Data Concepts:
* HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
* HIV.A.DE18: Gender* | Gender of the client*
* HIV.A.DE19: Female | Client identifies as female
* HIV.A.DE20: Male | Client identifies as male
* HIV.A.DE21: Transgender male | Client identifies as transgender male
* HIV.A.DE22: Transgender female | Client identifies as transgender female
* HIV.A.DE23: Other | Additional category
* HIV.C.DE75: Medications prescribed | Medications the client was prescribed
* HIV.C.DE76: PrEP for HIV prevention | Client was prescribed pre-exposure prophylaxis (PrEP) for HIV prevention
* HIV.C.DE77: PEP for HIV prevention | Client was prescribed post-exposure prophylaxis (PEP) for HIV prevention
* HIV.C.DE78: Other | Client was prescribed other medications
* HIV.D.DE457: Medications prescribed | Name or regimen code of all other medications prescribed during the visit
* HIV.PRV.DE17: Date OAMT initiated | Date client initiated opioid agonist maintenance treatment (OAMT)
* HIV.PRV.DE25: Date of loss to follow-up or OAMT stopped | Date of loss to follow-up or opioid agonist maintenance treatment (OAMT) stopped
* HIV.Config.DE20: Reporting period end date | End date of the reporting period
* HIV.Config.DE21: Reporting period start date | Start date of the reporting period
*
* Additional Context
* - what it measures: Measure of the proportion of person time in which individuals who are opioid dependent are covered by OAMT.
* - rationale: Evidence demonstrates that HIV risk is reduced among individuals who are opioid dependent during periods when receiving OAMT.
* - method: Individual-level data obtained from programme records.
*
* Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
*/
library HIVIND12Logic
// Included Libraries
using FHIR version '4.0.1'
include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include WHOCommon called WCom
include HIVElements called HE
include HIVIndicatorElements called HIE
// Indicator Definition
parameter "Measurement Period" Interval<DateTime> default Interval[@2023-01-01, @2023-01-30]
context Patient
/* Populations */
/*
*Initial Population
*/
define "Initial Population":
true
/**
* Numerator
*
* Definition: Total PYFU on OAMT during defined reporting period. | Calculated from the sum of the time on OAMT of each OAMT recipient during the reporting period.
* Calculation: SUM of [DIFFERENCE in MIN("Date OAMT initiated", "Reporting period start date") and MAX("Date of loss to follow-up or OAMT stopped", "Reporting period end date")] for all clients with "Medications prescribed" IN 'Methadone', 'Buprenorphine'
*/
define "Measure Population":
exists(HIE."buprenorphine_prescribed at date") or exists(HIE."methadone_prescribed at date")
define "Measure Observation":
(
difference in days between
Min(
{
ToDate(First(HIE."OAMT start")),
ToDate(start of "Measurement Period")
}
)
and ToDate(start of "Measurement Period")
)
+
(
difference in days between end of "Measurement Period"
and Coalesce(
ToDate(First(HIE."OAMT end")),
end of "Measurement Period"
)
)
/**
* Denominator
*
* Definition: a) Programme/service provider level: estimated PYFU for all opioid dependent people accessing service during defined reporting period | b) Population level: estimated PYFU for total population of opioid dependent people in relevant geographic area during defined reporting period
* Calculation: Service level: Not calculated in DAK | | Population denominator: | *Estimated PYFU for all opioid-dependent people accessing service during defined reporting period | | Note: Can be reported only as numerator; by population or service level if these denominator estimates available.
*/
/* end Populations */
</code></pre></td></tr>
</table>
</td>
</tr>
</table>
</div>
</div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
<valueCode value="computable"/>
</extension>
<url value="http://smart.who.int/hiv/Library/HIVIND12Logic"/>
<version value="0.4.3"/>
<name value="HIVIND12Logic"/>
<title value="HIV.IND.12 Logic"/>
<status value="draft"/>
<experimental value="true"/>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/library-type"/>
<code value="logic-library"/>
</coding>
</type>
<date value="2025-02-07T14:15:45+00:00"/>
<publisher value="WHO"/>
<contact>
<name value="WHO"/>
<telecom>
<system value="url"/>
<value value="http://who.int"/>
</telecom>
</contact>
<description
value="% of person-years of follow-up (PYFU) on OAMT among opioid dependent people"/>
<content>
<contentType value="text/cql"/>
<data
value="/**
 * Library: HIV.IND.12 Logic
 * Ref No: PRV.12
 * Short Name: Total person-years on OAMT
 *
 * Definition: % of person-years of follow-up (PYFU) on OAMT among opioid dependent people
 *
 * Numerator: Total PYFU on OAMT during defined reporting period. | Calculated from the sum of the time on OAMT of each OAMT recipient during the reporting period.
 * Numerator Calculation: SUM of [DIFFERENCE in MIN("Date OAMT initiated", "Reporting period start date") and MAX("Date of loss to follow-up or OAMT stopped", "Reporting period end date")] for all clients with "Medications prescribed" IN 'Methadone', 'Buprenorphine'
 * Numerator Exclusions: 
 *
 * Denominator: a) Programme/service provider level: estimated PYFU for all opioid dependent people accessing service during defined reporting period | b) Population level: estimated PYFU for total population of opioid dependent people in relevant geographic area during defined reporting period
 * Denominator Calculation: Service level: Not calculated in DAK |  | Population denominator:  | *Estimated PYFU for all opioid-dependent people accessing service during defined reporting period |  | Note: Can be reported only as numerator; by population or service level if these denominator estimates available.
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (female, male, other*) 
 *  • Age (15–19, 20–24, 25–49, 50+ years) 
 *  • Provider type (key population-led or community-led organization, public sector provider, other entities such as private for-profit and not-for-profit organizations, including faith-based, international, nongovernmental) 
 *  • Setting: facility-based service (including hospitals, health clinics, general practice offices, etc.) or community-based service (including drop-in centres, community service delivery points, mobile clinics or vans, outreach teams, community support groups, etc.) 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age
 *
 * Numerator and Denominator Elements:
 * Date OAMT initiated 
 *  Date of loss to follow-up or OAMT stopped 
 *  Medications prescribed 
 *  Reporting period end date 
 *  Reporting period start date
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.C.DE75: Medications prescribed | Medications the client was prescribed
 * HIV.C.DE76: PrEP for HIV prevention | Client was prescribed pre-exposure prophylaxis (PrEP) for HIV prevention
 * HIV.C.DE77: PEP for HIV prevention | Client was prescribed post-exposure prophylaxis (PEP) for HIV prevention
 * HIV.C.DE78: Other | Client was prescribed other medications
 * HIV.D.DE457: Medications prescribed | Name or regimen code of all other medications prescribed during the visit
 * HIV.PRV.DE17: Date OAMT initiated | Date client initiated opioid agonist maintenance treatment (OAMT)
 * HIV.PRV.DE25: Date of loss to follow-up or OAMT stopped | Date of loss to follow-up or opioid agonist maintenance treatment (OAMT) stopped
 * HIV.Config.DE20: Reporting period end date | End date of the reporting period
 * HIV.Config.DE21: Reporting period start date | Start date of the reporting period
 *
 * Additional Context
 * - what it measures: Measure of the proportion of person time in which individuals who are opioid dependent are covered by OAMT.
 * - rationale: Evidence demonstrates that HIV risk is reduced among individuals who are opioid dependent during periods when receiving OAMT.
 * - method: Individual-level data obtained from programme records.
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND12Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'

include WHOCommon called WCom

include HIVElements called HE
include HIVIndicatorElements called HIE

// Indicator Definition
parameter "Measurement Period" Interval<DateTime> default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define "Initial Population":
  true

/**
 * Numerator
 * 
 * Definition: Total PYFU on OAMT during defined reporting period. | Calculated from the sum of the time on OAMT of each OAMT recipient during the reporting period.
 * Calculation: SUM of [DIFFERENCE in MIN("Date OAMT initiated", "Reporting period start date") and MAX("Date of loss to follow-up or OAMT stopped", "Reporting period end date")] for all clients with "Medications prescribed" IN 'Methadone', 'Buprenorphine'
 */

define "Measure Population":
  exists(HIE."buprenorphine_prescribed at date") or exists(HIE."methadone_prescribed at date")


define "Measure Observation":
  (
    difference in days between
    Min(
      {
        ToDate(First(HIE."OAMT start")), 
        ToDate(start of "Measurement Period")
      }
    )

    and ToDate(start of "Measurement Period")
  )
  +
  (
    difference in days between end of "Measurement Period"
    and Coalesce(
        ToDate(First(HIE."OAMT end")), 
        end of "Measurement Period"
      )
  )
  
/**
 * Denominator
 *
 * Definition: a) Programme/service provider level: estimated PYFU for all opioid dependent people accessing service during defined reporting period | b) Population level: estimated PYFU for total population of opioid dependent people in relevant geographic area during defined reporting period
 * Calculation: Service level: Not calculated in DAK |  | Population denominator:  | *Estimated PYFU for all opioid-dependent people accessing service during defined reporting period |  | Note: Can be reported only as numerator; by population or service level if these denominator estimates available.
 */

/* end Populations */

"/>
</content>
</Library>